Calumet, Inc. (CLMT): A Bear Case Theory

We came across a bearish thesis on Calumet, Inc. (CLMT) on X(Twitter) by @puppyeh1. In this article, we will summarize the bears’ thesis on CLMT. Calumet, Inc. (CLMT)'s share was trading at $14.40 as of 29^th May. CLMT’s trailing and forward P/E were 23.06 and 11.35, respectively, according to Yahoo Finance.

[caption id="attachment_1229612" align="aligncenter" width="768"] Chemists in a laboratory studying beakers of liquid as they work to develop biopharmaceuticals for chronic inflammation and asthma.[/caption]

Calumet Specialty Products ($CLMT) is currently facing significant...